Sanofi

SAN
Real-time Euronext Paris - 09/17 05:37:32 pm
80EUR
+1.15%

Short-term turn-around to the downside ahead

Envoyer par e-mail
Jordan Dufee
Analyst

Strategy published on : 09/10/2019 | 03:17

short sell
Live

Entry price : 77.8€
Target : 72.3€
Stop-loss : 81.6€
Potential : 7.07%

The recently observed upswing has shown some signs of exhaustion, which makes for good timing to employ a short strategy with a short term perspective.
Investors should open a short trade and target the € 72.3.

Summary

● For a short-term investment strategy, the company has poor fundamentals.


Strengths

● The company returns high margins, thereby supporting business profitability.

● Over the last seven days, analysts have been revising upwards their EPS estimates for the company.

● Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.

● The stock is in a well-established, long-term rising trend above the technical support level at 75.95 EUR


Weaknesses

● Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

● With a 2019 P/E ratio at 25.45 times the estimated earnings, the company operates at rather significant levels of earnings multiples.

● For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.

Zonebourse.com 2019
Envoyer par e-mail